A Runaway Hit In US, Pfizer Gains EU Nod for Vyndaqel In Cardiomyopathy

Company Considers Using AI To Boost Diagnoses

 
• By Andrew McConaghie

Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.

NEW YORK CITY - MAY 2015: Metal plate logo of Pfizer in his headquarters building. Pfizer is an American multinational pharmaceutical corporation, one of the world's largest pharmaceutical companies.

More from Business

More from Scrip